Trademark Overview
On Friday, August 22, 2025, a trademark application was filed for PERSEUS SENOLYTIX with the United States Patent and Trademark Office. The USPTO has given the PERSEUS SENOLYTIX trademark a serial number of 99351616. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, January 13, 2026. This trademark is owned by SENOTHERAPEUTIX, Inc.. The PERSEUS SENOLYTIX trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Anti-cancer therapy;Anti-cancer services;Anti-cancer research;Anti-aging therapy;Anti-aging services;Anti-aging research;Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders;Development of pharmaceutical preparations and medicines;Research and development of pharmaceuticals for the treatment of cancer and age-related diseases;Testing, inspection, research, or development of pharmaceutical preparations for cancer therapy and age therapy;Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics;Peptides for use in cancer and age-related diseases;Peptides for use in skin conditions;Anti-cancer peptides;Anti-aging peptides;Peptides for use in prevention of radiation damage;Peptides for use in treatment of radiation damage;Peptides for use in prevention of radiation related diseases;Peptides for use in treatment of radiation related diseases;Biologic age scoring;Statisti...
Medical research services;Medical research services, namely, anti-cancer and anti-aging services;Medical research services, namely, prevention and treatment of cancer and age-related disorders;Medical advisory services;Medical advisory services, namely, anti-cancer and anti-aging services;Medical advisory services, namely, prevention and treatment of cancer and age-related disorders;Medical testing services;Medical testing services, namely, anti-cancer and anti-aging services;Medical testing services, namely, prevention and treatment of cancer and age-related disorders;Medical services in the field of anti-cancer and anti-aging;Medical services in the field of senescent cells;Medical services in the field of cancer and age-related disorders;Biopsy services;Biopsy services related to cancer;Biopsy services related to biologic age;Biopsy services related to biological age scoring;Biopsy services related to determining a number or percentage of senescent cells;Laboratory services;Laborato...
